Literature DB >> 6077416

Rubella virus: continuous and concurrent production of complement-fixing antigen and infectious virus in suspension cultures.

M M Vincent, G L Gitnick, A Fabiyi, S A Hensen, J L Sever, R J Huebner.   

Abstract

Rubella complement-fixing (CF) antigen and infectious virus were produced continuously and concurrently for as long as 63 days in suspension cultures of BHK-21 cells prepared from uncloned monolayer stock cultures. CF titers ranged from 1:4 to 1:32, and the peak infectivity titer was greater than 8.0 (TCID(50) log(10)) per ml. Suspension cultures could be recultivated after prolonged storage in liquid nitrogen. The resulting monolayer or suspension cultures also produced CF antigen. Suspension cultures provide an effective system for the long-term continuous and concurrent production of rubella virus diagnostic reagents.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6077416      PMCID: PMC547164          DOI: 10.1128/am.15.5.1198-1201.1967

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  9 in total

1.  Amino acid metabolism in mammalian cell cultures.

Authors:  H EAGLE
Journal:  Science       Date:  1959-08-21       Impact factor: 47.728

2.  RUBELLA COMPLEMENT FIXATION TEST.

Authors:  J L SEVER; R J HUEBNER; G A CASTELLANO; P S SARMA; A FABIYI; G M SCHIFF; C L CUSUMANO
Journal:  Science       Date:  1965-04-16       Impact factor: 47.728

3.  Rubella virus.

Authors:  J L SEVER; G M SCHIFF; R G TRAUB
Journal:  JAMA       Date:  1962-11-10       Impact factor: 56.272

4.  Polyoma transformation of hamster cell clones--an investigation of genetic factors affecting cell competence.

Authors:  I MACPHERSON; M STOKER
Journal:  Virology       Date:  1962-02       Impact factor: 3.616

5.  Cytopathic effect of rubella virus in RHK21 cells and growth to high titers in suspension culture.

Authors:  A Vaheri; W D Sedwick; S A Plotkin; R Maes
Journal:  Virology       Date:  1965-10       Impact factor: 3.616

6.  Production of rubella complement fixing antigen in BHK-21 cells.

Authors:  K Schell; K T Wong; H C Turner; R J Huebner
Journal:  Proc Soc Exp Biol Med       Date:  1966-12

7.  Rubella virus: growth characteristics and stability of infectious virus and complement-fixing antigen.

Authors:  A Fabiyi; J L Sever; N Ratner; B Caplan
Journal:  Proc Soc Exp Biol Med       Date:  1966-06

8.  The freezing of human kidney cell suspensions.

Authors:  V P Perry; C C Kerby; F J Kowalski; T I Malinin
Journal:  Cryobiology       Date:  1965 Mar-Apr       Impact factor: 2.487

9.  RUBELLA VIRUS: NEUTRALIZING ANTIBODY IN COMMERCIAL GAMMA GLOBULIN.

Authors:  G M SCHIFF; J L SEVER; R J HUEBNER
Journal:  Science       Date:  1963-10-04       Impact factor: 47.728

  9 in total
  3 in total

1.  Rubella virus RNA: effect of high multiplicity passage.

Authors:  G M Terry; L Ho-Terry; A Cohen; P Londesborough
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

2.  Production of rubella hemagglutinating antigen in suspension cultures.

Authors:  G L Gitnick; M M Vincent; A Auletta; A Ley; N Tzan; J L Sever
Journal:  Appl Microbiol       Date:  1967-09

3.  Impaired cellular immunity to rubella virus in congenital rubella.

Authors:  D A Fuccillo; R W Steele; S A Hensen; M M Vincent; J B Hardy; J A Bellanti
Journal:  Infect Immun       Date:  1974-01       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.